Halozyme

Illustration connected puzzle pieces with the acronym MA
Favicon Fierce Pharma

Halozyme catches M&A wave to snap up Surf Bio

With IP protections extending into the mid-2040s, both Elektrofi & Surf could provide long-term, durable royalty revenue streams, Halozyme's CEO said.
Angus Liu Jan 28, 2026 2:06pm
Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am
puzzle pieces merger and acquisition business concept
Favicon Fierce Pharma

Halozyme buys Elektrofi for up to $900M

Oct 1, 2025 2:36pm
Parachute

Baynes ditches Merck for CMO role at Eikon—Chutes and Ladders

Mar 25, 2022 9:30am
Helen Torley Halozyme CEO

Life after R&D death: Halozyme's pivot and path to profitability

Aug 10, 2020 4:01pm
People around a conference table headed by a black woman

BIO's first breakdown of diversity: 'We can do better'

Jan 31, 2020 9:55am